Insights

Gathering insights about AARDVARK…

Similar companies to AARDVARK

AARDVARK Tech Stack

AARDVARK uses 8 technology products and services including jsDelivr, Open Graph, RSS, and more. Explore AARDVARK's tech stack below.

jsDelivr
Content Delivery Network
Open Graph
Content Management System
RSS
Content Management System
Swiper
Javascript Libraries
WP Engine
Platform As A Service
Yoast SEO
Search Engines
Contact Form 7
Web Platform Extensions
Nginx
Web Servers

Media & News

Biotechs Highlight 6 Stocks Insiders Are Buying Now
Biotech companies saw the most notable insider purchases of the past week, including at the latest of the recent handful of biotech initial public offerings.
Feb 23, 2025 | 247wallst.com
U.S. IPO Weekly Recap: Big Listings Post Mixed Results In Busy 7 IPO Week
Seven IPOs and three SPACs were listed this week. Seven IPOs and four SPACs submitted initial filings. Some small IPOs are tentatively scheduled for the short holiday week ahead.
Feb 14, 2025 | seekingalpha.com
Aardvark Therapeutics Announces Pricing of Initial Public Offering
SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (“Aardvark”) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today announced the pricing of its initial public offering of 5,888,000 shares of its common stock at a public offering price of $16.00 per share. All of the shares are being offered by Aardvark. The gross proceeds to Aardvark from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $94.2 million. Aardvark's common stock is expected to begin trading on the Nasdaq Global Select Market on February 13, 2025 under the ticker symbol “AARD.” The offering is expected to close on February 14, 2025, subject to the satisfaction of customary closing conditions. In addition, Aardvark has granted the underwriters a 30-day option to purchase up to an additional 883,200 shares of common stock at the public offering price, less underwriting discounts and commissions.
Feb 12, 2025 | www.globenewswire.com
U.S. IPO Weekly Recap: Cement And Cystic Fibrosis Drugs Lead A 6 IPO Week
Two sizable companies and a handful of small Asian issuers were listed in the US this past week. Four small Asia-based issuers also went public in the US - EPWK Holdings, FBS Global, Plutus Financial Group, and Huachen AI Parking Management Technology. Eight IPOs are currently scheduled to list in the week ahead, although some small issuers may also join the calendar throughout the week.
Feb 08, 2025 | seekingalpha.com
Aardvark Therapeutics Starts $100 Million IPO Effort For Hunger Treatments
Aardvark Therapeutics aims to raise $100 million in an IPO to fund its clinical-stage biopharma treatments for metabolic conditions, including Prader-Willi syndrome. Its lead candidate ARD-101, targeting hyperphagia, is entering Phase 3 trials with topline data expected in early 2026. The PWS market is projected to exceed $1 billion by 2034, presenting significant growth potential despite its rarity.
Feb 03, 2025 | seekingalpha.com

AARDVARK's Email Address Formats

AARDVARK uses at least 1 format(s):

AARDVARK Email Formats	Example	Percentage
FLast@aardvarktactical.com	JDoe@aardvarktactical.com	49%
First@aardvarktactical.com	John@aardvarktactical.com	1%
F.Last@aardvarktactical.com	J.Doe@aardvarktactical.com	1%
FLast@aardvarktactical.com	JDoe@aardvarktactical.com	49%

Frequently Asked Questions

Where is AARDVARK's headquarters located?

AARDVARK's main headquarters is located at 1935 Puddingstone Drive La Verne, CA 91750 US. The company has employees across 4 continents, including North AmericaAfricaEurope.

What is AARDVARK's phone number?

You can contact AARDVARK's main corporate office by phone at

+1-909-451-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is AARDVARK's stock symbol?

AARDVARK is a publicly traded company; the company's stock symbol is AARD.

What is AARDVARK's official website and social media links?

AARDVARK's official website is aardvarktactical.com and has social profiles on LinkedIn.

How much revenue does AARDVARK generate?

As of December 2024, AARDVARK's annual revenue reached $3.8M.

What is AARDVARK's SIC code NAICS code?

AARDVARK's SIC code is 5999 - Miscellaneous Retail Stores, Not Elsewhere Classified NAICS code is 448210 - Shoe Stores.

How many employees does AARDVARK have currently?

As of December 2024, AARDVARK has approximately 39 employees across 4 continents, including North AmericaAfricaEurope. Key team members include CEO & President: J. B.Chief Executive Officer: B. G.President: A. E.. Explore AARDVARK's employee directory with LeadIQ.

What industry does AARDVARK belong to?

AARDVARK operates in the Defense and Space Manufacturing industry.

What technology does AARDVARK use?

AARDVARK's tech stack includes jsDelivrOpen GraphRSSSwiperWP EngineYoast SEOContact Form 7Nginx.

What is AARDVARK's email format?

AARDVARK's email format typically follows the pattern of . Find more AARDVARK email formats with LeadIQ.

When was AARDVARK founded?

AARDVARK was founded in 1986.

AARDVARK

Defense and Space ManufacturingCalifornia, United States11-50 Employees

The mission of AARDVARK is to protect tactical operators.  We accomplish this by providing cutting edge, professional quality, protective products and integrated systems to military, federal, state, and local tactical teams.